Events

FET Pitch event
MAR
Tue
26
16:00 - 18:00

This was 6 years ago

Location

Programmes
FET SwafS

The Swafs project "COMPASS - Evidence and Opportunities for Responsible Innovation in SMEs" joined forces with the FET-Open CSA project FET2RIN

They want to highlight the challenges of investing in R&D&I projects and to present very promising technologies looking for investment – both locally and internationally.

The FET Pitch event is part of the final conference of the project COMPASS and gives 10 disruptive Future and Emerging Technologies projects the opportunity to pitch their innovation in front of the audience and a panel composed of a.o. young investors. They are prepared for the pitch by two FET2RIN trainings.

More information about the programme can be found on the websites of FET2RIN and COMPASS.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.